Related Experiment Video

Updated: Nov 28, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.5K

Effects of salvianolate on myocardial perfusion after primary percutaneous catheter intervention in patients with

Li Shen1,2, Rende Xu1,2, Jiasheng Yin1,2

  • 1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Annals of Translational Medicine
|November 26, 2020
PubMed

Insights

Salvianolate improved myocardial perfusion in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). Further research is needed to confirm its impact on clinical outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Research

Background:

  • Acute myocardial infarction (AMI) frequently results in poor myocardial perfusion due to microvascular dysfunction, impacting patient outcomes.
  • ST-segment-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) often experience impaired microcirculation.
  • Impaired microvascular circulation post-PCI is a significant predictor of adverse cardiac events.

Purpose of the Study:

  • To investigate the efficacy of salvianolate in enhancing myocardial perfusion in STEMI patients undergoing primary PCI.
  • To evaluate the impact of salvianolate on epicardial and myocardial reperfusion.
  • To assess salvianolate's effects on infarct size, left ventricular ejection fraction, and clinical outcomes.

Main Methods:

  • A randomized, double-blind, placebo-controlled, multicenter trial involving 536 STEMI patients.
  • Patients received either intravenous salvianolate or a placebo after primary PCI.
  • Key outcome measures included myocardial perfusion (grades 3), infarct size (CK-MB), ejection fraction, and 30-day clinical events.

Main Results:

  • Salvianolate administration demonstrated positive effects on coronary microcirculation.
  • A trend towards reduced myocardial infarct size was observed in the salvianolate group (P=0.070).
  • No significant difference in left ventricular ejection fraction was found between salvianolate and placebo groups.

Conclusions:

  • Salvianolate treatment is linked to improved myocardial perfusion in STEMI patients undergoing PCI.
  • The study suggests a potential benefit of salvianolate for microvascular function post-PCI.
  • A larger clinical trial is warranted to determine the definitive impact of salvianolate on clinical cardiac outcomes.
Abstract

Keywords:
Salvianolatecoronary interventionmyocardial infarctionmyocardial perfusionprimary percutaneous

More Related Videos

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.8K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.7K

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
603
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
108
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
399
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
104